Ugandan scientists welcome twice-yearly injection against HIV
"After over a decade of working on HIV PrEP trials, it's extremely fulfilling to get such amazing results from the PURPOSE1 study,” said Dr Flavia Matovu Kiweewa.
PREMIUM Health
Dr Flavia Matovu Kiwewa and Linda-Gail Bekker, the director of the Desmond Tutu HIV Center at the University of Cape Town welcomed the new study. Courtesy photo
By NewVision Reporter
Journalists @NewVision
A groundbreaking research done in Uganda and South Africa has shown that Lenacapavir, an injectable drug administered once in six months to prevent HIV infection, is 100% effective